ERBB2 and breast cancer: Our findings related to morphology-based prediction of the ERBB2 status are in line with those from a recent study, in which a deep learning-based method was used to predict ERBB2 and a series of other biomarkers in breast cancer from H&E-stained tissue microarray spots11,12.